BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1339 related articles for article (PubMed ID: 24113319)

  • 1. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
    Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
    Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.
    Goonewardene SS; Persad R; Young A; Makar A
    Eur Urol; 2014 Sep; 66(3):e51-2. PubMed ID: 24813269
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
    BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.
    Galvão DA; Spry N; Taaffe DR; Denham J; Joseph D; Lamb DS; Levin G; Duchesne G; Newton RU
    BMC Cancer; 2009 Dec; 9():419. PubMed ID: 19951446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy.
    Edmunds K; Reeves P; Scuffham P; Galvão DA; Newton RU; Jones M; Spry N; Taaffe DR; Joseph D; Chambers SK; Tuffaha H
    Appl Health Econ Health Policy; 2020 Oct; 18(5):727-737. PubMed ID: 32107736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity training following lung cancer surgery: a randomised controlled trial.
    Edvardsen E; Skjønsberg OH; Holme I; Nordsletten L; Borchsenius F; Anderssen SA
    Thorax; 2015 Mar; 70(3):244-50. PubMed ID: 25323620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
    Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
    Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.
    Østergren P; Ragle AM; Jakobsen H; Klausen TW; Vinther A; Sønksen J
    BMJ Open; 2016 Jun; 6(6):e011460. PubMed ID: 27357198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    J Urol; 2011 Oct; 186(4):1291-7. PubMed ID: 21849187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    J Clin Oncol; 2010 Jan; 28(2):340-7. PubMed ID: 19949016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Sigal RJ; Kenny GP; Prud'Homme DG; Malone SC; Wells GA; Scott CG; Slovinec D'Angelo ME
    J Clin Oncol; 2009 Jan; 27(3):344-51. PubMed ID: 19064985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy.
    Beydoun N; Bucci JA; Chin YS; Spry N; Newton R; Galvão DA
    J Med Imaging Radiat Oncol; 2014; 58(3):369-76. PubMed ID: 24118798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study.
    Gaskin CJ; Fraser SF; Owen PJ; Craike M; Orellana L; Livingston PM
    J Cancer Surviv; 2016 Dec; 10(6):972-980. PubMed ID: 27098346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
    J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.
    Buffart LM; Galvão DA; Chinapaw MJ; Brug J; Taaffe DR; Spry N; Joseph D; Newton RU
    Cancer; 2014 Jan; 120(2):294-301. PubMed ID: 24122296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.